Loading news...
MQS Management LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE: CAH) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 3,977 shares of the company's stock, valued at approximately $624,000. Several other institutional investors have also recently
Candriam S.C.A. grew its holdings in shares of Cardinal Health, Inc. (NYSE: CAH) by 10.8% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 196,163 shares of the company's stock after acquiring an additional 19,155 shares during the period. Candriam S.C.A. owned about 0.08% of Cardinal
Versor Investments LP purchased a new position in Cardinal Health, Inc. (NYSE: CAH) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 13,313 shares of the company's stock, valued at approximately $2,090,000. Cardinal Health makes up about 0.4%
The 2025 Q4 earnings season continues to be one of positivity, with several companies, including these two that sport buy ratings, knocking it out of the park and raising their outlooks.
ProShare Advisors LLC lowered its stake in Cardinal Health, Inc. (NYSE: CAH) by 9.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,108,450 shares of the company's stock after selling 120,405 shares during the quarter. ProShare Advisors LLC owned
Ironwood Investment Counsel LLC trimmed its stake in Cardinal Health, Inc. (NYSE: CAH) by 20.4% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 25,218 shares of the company's stock after selling 6,447 shares during the quarter. Ironwood Investment Counsel LLC's holdings in Cardinal Health were
Cardinal Health is upgraded to a buy after Q2 2026 delivered robust revenue, margin expansion, and raised full-year guidance. Q2 revenue grew 19% YoY to $65.6B, with non-GAAP EPS up 36% and broad-based segment strength, especially in pharmaceuticals. Management executed $750M in share repurchases YTD, underscoring commitment to capital return and reducing outstanding shares by 2.5%.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cardinal Health (NYSE: CAH) reported fiscal second-quarter 2026 results that management described as "another excellent quarter," citing broad-based momentum across the portfolio and double-digit profit growth in each of its five operating segments. Executives also raised full-year earnings guidance again, pointing to strong demand trends and continued execution in the company's core pharmaceutical distribution business, expanding
Cardinal Health, Inc. (NYSE: CAH - Get Free Report)'s stock price gapped up before the market opened on Thursday after the company announced better than expected quarterly earnings. The stock had previously closed at $206.85, but opened at $217.00. Cardinal Health shares last traded at $227.2750, with a volume of 627,667 shares. The company reported $2.63
Total Revenue: Increased 19% to $66 billion.Gross Margin: Increased 24% to $2.4 billion.SG&A Expenses: Increased 16% to $1.5 billion.Operating Earnings: Increa
Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%.
Cardinal Health (CAH) saw its stock soar after reporting impressive Q2 2026 results that surpassed expectations and raising its FY26 outlook for the second time
CAH tops second-quarter fiscal 2026 EPS estimates by 10%, posts strong segment profits, and raises full-year earnings outlook, sending shares higher.
The pharmaceutical distributor and health services company raises its guidance for the second time.
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cardinal Health (CAH) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $1.93 per share a year ago.
Cardinal Health on Thursday raised its expectations for annual profit after surpassing Wall Street estimates for quarterly results, as it bets on robust demand for specialty medicines and strong performance across its segments.
Cardinal Health raised its outlook for the year after logging higher profit and revenue in its fiscal second quarter.